Animal experiments showed that the combination of P3C–Asp with immune checkpoint inhibitors aPD‐1 increased the infiltration of CD8+ T cells, M1 macrophages, and the ratio of M1 over M2 macrophages, which effectively inhibited tumor growth without obvious side effects.[68] Wan et al. Here, CD8A is linked to neoplasm.